aminocaproic acid has been researched along with Bilirubinemia in 1 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
Excerpt | Relevance | Reference |
---|---|---|
"The prolonged administration of epsilon-aminocaproic acid (EACA) resulted in the development of severe proximal myopathy associated with high plasma creatine kinase values, rhabdomyolysis, myoglobinuria, and mild hyperbilirubinaemia." | 3.66 | Epsilon-aminocaproic acid-induced myopathy. A case report. ( Berman, PA; Jacobs, P; Morris, CD; Rutherfoord, GS, 1983) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Morris, CD | 1 |
Jacobs, P | 1 |
Berman, PA | 1 |
Rutherfoord, GS | 1 |
1 other study available for aminocaproic acid and Bilirubinemia
Article | Year |
---|---|
Epsilon-aminocaproic acid-induced myopathy. A case report.
Topics: Adult; Aminocaproates; Aminocaproic Acid; Animals; Cathepsin D; Cathepsins; Creatine Kinase; Female; | 1983 |